Comment on: The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: Benefits versus risks [7]

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 1, 2008, Pages 227-

  Deane, Adam ^a   Young, Robert ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Critical illness; Delayed gastric emptying; Intensive care

Indexed keywords

CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; ERYTHROMYCIN; GHRELIN AGONIST; MACROLIDE; METOCLOPRAMIDE; MOTILIN AGONIST; OPIATE; PROKINETIC AGENT; TEGASEROD; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; CARDIOVASCULAR DISEASE; CRITICALLY ILL PATIENT; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG USE; ENTERIC FEEDING; FOOD AND DRUG ADMINISTRATION; GASTRIC DYSMOTILITY; HUMAN; INTENSIVE CARE UNIT; ISCHEMIA; LETTER; NUTRITIONAL INTOLERANCE; NUTRITIONAL SUPPORT; RISK BENEFIT ANALYSIS; SHORT COURSE THERAPY; STOMACH EMPTYING; STOMACH MOTILITY; TACHYPHYLAXIS;

ADULT; CRITICAL CARE; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GASTROINTESTINAL AGENTS; GASTROINTESTINAL MOTILITY; HUMANS;

EID: 37549003990     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm419     Document Type: Letter

References (6)

1. Hawkyard CV, Koerner RJ. The use of erythromycin as a gastro-intestinal prokinetic agent in adult critical care: Benefits versus risks. J Antimicrob Chemother 2007; 59: 347-58.
2. Chapman M, Fraser R, Vozzo R et al. Antro-pyloro-duodenal motor responses to gastric duodenal nutrient in critically ill patients. Gut 2005; 54: 1384-90.
3. Nguyen NQ, Chapman MJ, Fraser RJ et al. Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness. Crit Care Med 2007; 35: 483-9.
4. Nguyen NQ, Chapman M, Fraser RJ et al. Prokinetic therapy for feed intolerance in critical illness: One drug or two? Crit Care Med 2007 [5 September 2007, Epub ahead of print].
5. Stephens DP, Thomas JH, Collins SJ et al. A clinical audit of the efficacy of tegaserod as a prokinetic agent in the intensive care unit. Crit Care Resusc 2007; 9: 148-50.
6. U.S. Food and Drug Administration. Zelnorm (Tegaserod Maleate) Information. http://www.fda.gov/cder/drug/infopage/zelnorm/ default.htm (21 October 2007, date last accessed).